Additionally, Fritzsching et al. reported that Tregs do notaccurately infiltrate the CNS during the progression of MS, while brain biopsies from patients with MS showed a lack of FoxP3 expression in 30% of lesions [71]. The gene discussed is FOXP3; the disease is myeloid sarcoma.